Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Condition-Specific Growth Charts for Children With Alagille Syndrome.

JAMA network open·2025
Same author

Autoimmune hepatitis in children: Guidelines of the Indian Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ISPGHAN).

Hepatology international·2025
Same author

Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the GALA Study Group.

Liver international : official journal of the International Association for the Study of the Liver·2025
Same author

Phenotypic Divergence of JAG1- and NOTCH2-Associated Alagille Syndrome & Disease-Specific NOTCH2 Variant Classification Guidelines.

Liver international : official journal of the International Association for the Study of the Liver·2025
Same author

The Society of Pediatric Liver Transplantation (SPLIT): 2023 Registry Status.

Pediatric transplantation·2025
Same author

Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated Cirrhosis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025

Related Experiment Video

Updated: Jun 13, 2026

Robot-Assisted Laparoscopic Splenectomy In Children: A Case Report with Literature Review
05:06

Robot-Assisted Laparoscopic Splenectomy In Children: A Case Report with Literature Review

Published on: March 27, 2026

Sclerosing cholangitis: pediatric perspective.

Nanda Kerkar1, Tamir Miloh

  • 1Department of Pediatrics, The Mount Sinai Medical Center, New York, NY, USA. nanda.kerkar@mountsinai.org

Current Gastroenterology Reports
|April 29, 2010
PubMed
Summary
This summary is machine-generated.

Primary sclerosing cholangitis (PSC) is a rare liver disease. While treatments manage symptoms, liver transplantation is the only life-extending option for advanced cases.

More Related Videos

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
04:14

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

Related Experiment Videos

Last Updated: Jun 13, 2026

Robot-Assisted Laparoscopic Splenectomy In Children: A Case Report with Literature Review
05:06

Robot-Assisted Laparoscopic Splenectomy In Children: A Case Report with Literature Review

Published on: March 27, 2026

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults
04:14

Laparoscopic Choledochal Cyst Excision and Roux-en-Y Choledochojejunostomy in Adults

Published on: February 28, 2025

Area of Science:

  • Hepatology
  • Gastroenterology
  • Autoimmune Diseases

Background:

  • Sclerosing cholangitis (SC) is a rare, progressive cholestatic liver disease impacting the biliary tract.
  • It can be associated with autoimmune hepatitis, immunodeficiencies, cystic fibrosis, and sickle cell disease.
  • Primary sclerosing cholangitis (PSC), a subset of SC, shows strong links to male gender, Caucasian race, and inflammatory bowel disease.

Purpose of the Study:

  • To summarize the key aspects of sclerosing cholangitis, including its associations, diagnosis, management, and prognosis.
  • To highlight the role of liver transplantation in managing advanced stages of the disease.

Main Methods:

  • Review of existing literature on sclerosing cholangitis.
  • Analysis of diagnostic criteria (biochemical, radiologic, histologic).
  • Evaluation of current medical management strategies and their efficacy.

Main Results:

  • Diagnosis relies on characteristic biochemical, radiologic, and histologic findings.
  • Medical management focuses on complications; ursodeoxycholic acid offers biochemical improvement but not proven survival benefit.
  • Immunosuppression benefits patients with autoimmune overlap; liver transplantation is the sole life-extending therapy.

Conclusions:

  • Sclerosing cholangitis is a progressive condition potentially leading to biliary cirrhosis and cholangiocarcinoma.
  • Orthotopic liver transplantation offers good long-term survival, though recurrence (PSC) affects approximately 10% of pediatric recipients.